FDA orphan drug designation: treatment of malignant glioma
All entries for: Celista Pharmaceuticals LLC
November 1, 2025
Celista Pharmaceuticals LLC
Orphan Drug Designation
Disease Area: Rare Diseases
FDA orphan drug designation: treatment of malignant glioma